eBook: Formulation of Dry Powder Inhaler - 19
28. Ionescu RM, Vlasak J, Price C, Kirchmeier M. Contribution of
variable domains to the stability of humanized IgG1 monoclonal
antibodies. J Pharm Sci. 2008;97(4):1414-26. https://doi.org/
10.1002/jps.21104.
29. Akbas S, Sahin A, Calis S, Oncel H, Capan Y. Characterization of
bevacizumab by dynamic light scattering while maintaining
its native structure. Die Pharmazie - An International Journal of
Pharmaceutical Sciences. 2018;73(7):369-74. https://doi.org/
10.1691/ph.2018.8024.
30. Boraey MA, Hoe S, Sharif H, Miller DP, Lechuga-Ballesteros D,
Vehring R. Improvement of the dispersibility of spray-dried
budesonide powders using leucine in an ethanol-water
cosolvent system. Powder Technol. 2013;236:171-8. https:// doi.
org/10.1016/j.powtec.2012.02.047.
31. Feng AL, Boraey MA, Gwin MA, Finlay PR, Kuehl PJ, Vehring
R. Mechanistic models facilitate efficient development of
leucine containing microparticles for pulmonary drug delivery.
Int J Pharm. 2011;409(1):156-63. https://doi.org/10.1016/
j.ijpharm.2011.02.049.
32. Vehring R. Pharmaceutical particle engineering via spray drying.
Pharm Res. 2008;25(5):999-1022. https://doi.org/ 10.1007/
s11095-007-9475-1.
33. Ordoubadi M, Gregson FKA, Wang H, Nicholas M, Gracin S,
Lechuga-Ballesteros D, et al. On the particle formation of
leucine in spray drying of inhalable microparticles. Int J Pharm.
2021;592:120102. https://doi.org/10.1016/j.ijpharm.2020.120102.
34. Mangal S, Meiser F, Tan G, Gengenbach T, Denman J, Rowles MR,
et al. Relationship between surface concentration of l-leucine
and bulk powder properties in spray dried formulations. Eur
J Pharm Biopharm. 2015;94:160-9. https://doi.org/10.1016/
j.ejpb.2015.04.035.
35. Sou T, Kaminskas LM, Nguyen T-H, Carlberg R, McIntosh MP,
Morton DAV. The effect of amino acid excipients on morphology
and solid-state properties of multi-component spray-dried
formulations for pulmonary delivery of biomacromolecules. Eur
J Pharm Biopharm. 2013;83(2):234-43. https://doi.org/10.1016/
j.ejpb.2012.10.015.
36. Zografi G, Newman A. Interrelationships between structure
and the properties of amorphous solids of pharmaceutical
interest. J Pharm Sci. 2017;106(1):5-27. https://doi.org/10.1016/j.
xphs.2016.05.001.
37. Roe KD, Labuza TP. Glass Transition and Crystallization of
amorphous trehalose-sucrose mixtures. Int J Food Prop.
2005;8(3):559-74. https://doi.org/10.1080/10942910500269824.
38. Ueda H, Aikawa S, Kashima Y, Kikuchi J, Ida Y, Tanino T, et al.
Anti-plasticizing effect of amorphous indomethacin induced by
specific intermolecular interactions with PVA copolymer. J Pharm
Sci. 2014;103(9):2829-38. https://doi.org/10.1002/jps.24023.
39. Shepard K. Pulmonary Delivery of Spray-Dried Monoclonal
Antibody Formulations 2021. White paper, lonza.com
40. Newman SP. Delivering drugs to the lungs: the history of
repurposing in the treatment of respiratory diseases. Adv
Drug Deliv Rev. 2018;133:5-18. https://doi.org/10.1016/j.
addr.2018.04.010.
41. Chow MYT, Qiu Y, Lam JKW. Inhaled RNA Therapy: from promise
to reality. Trends Pharmacol Sci. 2020;41(10):715-29. https://doi.
org/10.1016/j.tips.2020.08.002.
42. Fröhlich E, Salar-Behzadi S. Oral inhalation for delivery of proteins
and peptides to the lungs. Eur J Pharm Biopharm. 2021;163:198-
211. https://doi.org/10.1016/j.ejpb.2021.04.003.
43. Society TA. Antibody therapeutics approved or in regulatory
review in the EU or US. 2021 [updated 4 March 2021]; Available
from: https://www.antibodysociety.org/resources/approvedantibodies/.
Webinar
On-Demand
19
https://www.doi.org/
https://www.doi.org/10.1080/10942910500269824
https://www.doi.org/10.1002/jps.24023
https://www.doi.org/
http://www.lonza.com
https://www.doi.org/10.1016/j
http://https://
https://doi
https://www.doi.org/10.1016/
https://www.doi.org/10.1016/j.ejpb.2021.04.003
https://www.doi.org/
https://www.antibodysociety.org/resources/approved
https://www.doi.org/10.1016/j.ijpharm.2020.120102
https://players.brightcove.net/5493668606001/45KoTGnQh_default/index.html?videoId=6300119694001
https://www.doi.org/10.1016/
https://www.doi.org/10.1016/
https://www.doi.org/10.1016/j
eBook: Formulation of Dry Powder Inhaler
Table of Contents for the Digital Edition of eBook: Formulation of Dry Powder Inhaler
eBook: Formulation of Dry Powder Inhaler - 1
eBook: Formulation of Dry Powder Inhaler - 2
eBook: Formulation of Dry Powder Inhaler - 3
eBook: Formulation of Dry Powder Inhaler - 4
eBook: Formulation of Dry Powder Inhaler - 5
eBook: Formulation of Dry Powder Inhaler - 6
eBook: Formulation of Dry Powder Inhaler - 7
eBook: Formulation of Dry Powder Inhaler - 8
eBook: Formulation of Dry Powder Inhaler - 9
eBook: Formulation of Dry Powder Inhaler - 10
eBook: Formulation of Dry Powder Inhaler - 11
eBook: Formulation of Dry Powder Inhaler - 12
eBook: Formulation of Dry Powder Inhaler - 13
eBook: Formulation of Dry Powder Inhaler - 14
eBook: Formulation of Dry Powder Inhaler - 15
eBook: Formulation of Dry Powder Inhaler - 16
eBook: Formulation of Dry Powder Inhaler - 17
eBook: Formulation of Dry Powder Inhaler - 18
eBook: Formulation of Dry Powder Inhaler - 19
eBook: Formulation of Dry Powder Inhaler - 20
eBook: Formulation of Dry Powder Inhaler - 21
eBook: Formulation of Dry Powder Inhaler - 22
eBook: Formulation of Dry Powder Inhaler - 23
eBook: Formulation of Dry Powder Inhaler - 24
eBook: Formulation of Dry Powder Inhaler - 25
eBook: Formulation of Dry Powder Inhaler - 26
eBook: Formulation of Dry Powder Inhaler - 27
eBook: Formulation of Dry Powder Inhaler - 28
eBook: Formulation of Dry Powder Inhaler - 29
eBook: Formulation of Dry Powder Inhaler - 30
eBook: Formulation of Dry Powder Inhaler - 31
eBook: Formulation of Dry Powder Inhaler - 32
eBook: Formulation of Dry Powder Inhaler - 33
eBook: Formulation of Dry Powder Inhaler - 34
eBook: Formulation of Dry Powder Inhaler - 35
eBook: Formulation of Dry Powder Inhaler - 36
eBook: Formulation of Dry Powder Inhaler - 37
eBook: Formulation of Dry Powder Inhaler - 38
eBook: Formulation of Dry Powder Inhaler - 39
eBook: Formulation of Dry Powder Inhaler - 40
eBook: Formulation of Dry Powder Inhaler - 41
eBook: Formulation of Dry Powder Inhaler - 42
eBook: Formulation of Dry Powder Inhaler - 43
eBook: Formulation of Dry Powder Inhaler - 44
eBook: Formulation of Dry Powder Inhaler - 45
eBook: Formulation of Dry Powder Inhaler - 46
eBook: Formulation of Dry Powder Inhaler - 47
https://www.nxtbookmedia.com